Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -333,000 | -126,000 | -250,000 | 49,000 | -261,000 |
| Other Working Capital | 297,000 | -278,000 | -552,000 | -207,000 | -302,000 |
| Other Operating Activity | 1,888,000 | 914,000 | 1,212,000 | 773,000 | 1,412,000 |
| Operating Cash Flow | $1,852,000 | $510,000 | $410,000 | $615,000 | $849,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 472,000 | -515,000 | -420,000 | -193,000 | -368,000 |
| Net Acquisitions | 66,000 | -29,000 | -152,000 | -38,000 | 341,000 |
| Purchase Of Investment | -1,294,000 | -428,000 | -61,000 | -19,000 | -25,000 |
| Sale Of Investment | 495,000 | 118,000 | 54,000 | N/A | 3,000 |
| Other Investing Activity | -223,000 | -42,000 | -251,000 | -407,000 | -55,000 |
| Investing Cash Flow | $-484,000 | $-896,000 | $-830,000 | $-657,000 | $-104,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 260,000 | 122,000 | 257,000 | 382,000 |
| Debt Repayment | -756,000 | -9,000 | -63,000 | -504,000 | -1,255,000 |
| Common Stock Issued | 185,000 | 104,000 | 284,000 | 188,000 | 215,000 |
| Other Financing Activity | 0 | -5,000 | -4,000 | 0 | 0 |
| Financing Cash Flow | $-546,000 | $350,000 | $339,000 | $-59,000 | $-658,000 |
| Exchange Rate Effect | -23,000 | 10,000 | -30,000 | -1,000 | 177,000 |
| Beginning Cash Position | 512,000 | 187,000 | 679,000 | 583,000 | -1,549,000 |
| End Cash Position | 1,311,000 | 161,000 | 568,000 | 481,000 | -1,285,000 |
| Net Cash Flow | $822,000 | $-36,000 | $-81,000 | $-101,000 | $87,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,852,000 | 510,000 | 410,000 | 615,000 | 849,000 |
| Capital Expenditure | -1,103,000 | -597,000 | -475,000 | -415,000 | -401,000 |
| Free Cash Flow | 749,000 | -87,000 | -65,000 | 200,000 | 448,000 |